Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled, multi-center clinical trial was conducted to
observe the improvement in the level of dyskinesia in patients with Parkinson's disease
during the 12-week period of oral treatment with Tianqi Pingchan Granule Combined With
Amantadine. To observe the differences of the safety and effectiveness between Tianqi
Pingchan Granule combined with amantadine and placebo combined with amantadine.
Phase:
N/A
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators:
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine Shanghai Municipal Hospital of Traditional Chinese Medicine Shanghai University of Traditional Chinese Medicine The Affiliated Hospital of Qingdao University The Affiliated Hospital of Xuzhou Medical University Wenzhou Central Hospital